Sign inJoin waitlistJoin the waitlist

SJ

Shilpa Johri

Physician · Pulmonary Associates of Richmond Inc

Credentials: · · · ·

History

Pulmonary Associates of Richmond Inc
Present

Anesthesiology Critical Care Medicine
New York Presbyterian Hospital
2002–2003
Pulmonary Disease and Critical Care Medicine
New York Presbyterian Hospital
2000–2003
Internal Medicine
Lincoln Medical and Mental Health Center
1997–2000
Sarojini Naidu Medical College
1992–1996

Research

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
The Lancet Respiratory Medicine · 2021 · 120 citations
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen
Annals of the American Thoracic Society · 2022 · 39 citations
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Pulmonary Circulation · 2022 · 36 citations

CK
Christopher King
4 papers
SN
Steven Nathan
4 papers
Joanna Joly
3 papers
Sandeep Sahay
3 papers
Aaron Waxman
2 papers
Abubakr Bajwa
2 papers
Amy Case
2 papers
Charles Burger
2 papers
Gansevoort Dunnington
2 papers
Gautam Ramani
2 papers
Harold Palevsky
2 papers
JM
Jinesh Mehta
2 papers

Clinical trials

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2024–2028
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Site PI · Recruiting · Phase 3
United Therapeutics
2023–2027